Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Journal of Lipid Research
|
May 5, 2009
A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis
Robert J Brown, Andrew C Edmondson, Nathalie Griffon, et al.
Journal of Lipid Research
|
February 6, 2009
Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism
Margaret E Brousseau, John S Millar, Margaret R Diffenderfer, et al.
The New England Journal of Medicine
|
January 12, 2007
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Marina Cuchel, LeAnne T Bloedon, Philippe O Szapary, et al.
Journal of Lipid Research
|
April 5, 2012
Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism
Margaret R Diffenderfer, Margaret E Brousseau, John S Millar, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2007
Innate immunity modulates adipokines in humans
Paul D Anderson, Nehal N Mehta, Megan L Wolfe, et al.
Thrombosis and Haemostasis
|
December 4, 2003
Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters
Stephanie Pitsilos, Jennifer Hunt, Emile R Mohler, et al.
Plos Genetics
|
December 17, 2011
Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol
Sumeet A Khetarpal, Andrew C Edmondson, Avanthi Raghavan, et al.
Atherosclerosis
|
March 30, 2012
Inflammation modulates human HDL composition and function in vivo
Margarita de la Llera Moya, Fiona C McGillicuddy, Christine C Hinkle, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome
John S Millar, Danielle Duffy, Ramprasad Gadi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 12, 2005
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion
Margaret E Brousseau, Margaret R Diffenderfer, John S Millar, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Journal of Lipid Research
|
May 5, 2009
A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis
Robert J Brown, Andrew C Edmondson, Nathalie Griffon, et al.
Journal of Lipid Research
|
February 6, 2009
Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism
Margaret E Brousseau, John S Millar, Margaret R Diffenderfer, et al.
The New England Journal of Medicine
|
January 12, 2007
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Marina Cuchel, LeAnne T Bloedon, Philippe O Szapary, et al.
Journal of Lipid Research
|
April 5, 2012
Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism
Margaret R Diffenderfer, Margaret E Brousseau, John S Millar, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2007
Innate immunity modulates adipokines in humans
Paul D Anderson, Nehal N Mehta, Megan L Wolfe, et al.
Thrombosis and Haemostasis
|
December 4, 2003
Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters
Stephanie Pitsilos, Jennifer Hunt, Emile R Mohler, et al.
Plos Genetics
|
December 17, 2011
Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol
Sumeet A Khetarpal, Andrew C Edmondson, Avanthi Raghavan, et al.
Atherosclerosis
|
March 30, 2012
Inflammation modulates human HDL composition and function in vivo
Margarita de la Llera Moya, Fiona C McGillicuddy, Christine C Hinkle, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome
John S Millar, Danielle Duffy, Ramprasad Gadi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 12, 2005
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion
Margaret E Brousseau, Margaret R Diffenderfer, John S Millar, et al.
Page
of 5